Microparticles for the delivery of DNA vaccines

Immunological Reviews
Derek T O'HaganJeffrey B Ulmer

Abstract

DNA vaccines have demonstrated a lack of adequate potency in humans, which has necessitated the exploration of various adjunct technologies. Inefficient delivery of DNA vaccines, particularly to antigen-presenting cells, may be contributing to this lack of potency. One effective means of facilitating delivery of DNA vaccines to APCs is through the use of microparticles. In this article, we review the background and rationale for microparticles as a vaccine delivery system, data demonstrating their utility and mode of action for DNA delivery, and the prospects for their development.

References

Oct 1, 1991·Vaccine·D T O'HaganS S Davis
Oct 1, 1996·The Journal of Experimental Medicine·M CorrH Tighe
Jan 1, 1997·Annual Review of Immunology·J J DonnellyM A Liu
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·L TimaresS A Johnston
Jul 22, 1999·The New England Journal of Medicine·R A Seder, S Gurunathan
Sep 9, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·E WalterH P Merkle
Jan 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·M SinghD O'Hagan
Apr 1, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·A M Tinsley-BownG H Farrar
Apr 26, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·G WideraJ B Ulmer
May 29, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·J KazzazD T O'Hagan
Jun 3, 2000·Annual Review of Immunology·S GurunathanR A Seder
Jun 6, 2000·Advanced Drug Delivery Reviews·D T O'Hagan
Aug 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M DupuisD M McDonald
Dec 29, 2000·Nature·H HemmiS Akira
Apr 3, 2001·Science·D Paydarfar, W J Schwartz
Jul 5, 2001·Gene Therapy·S E ParkerJ A Norman

❮ Previous
Next ❯

Citations

Dec 3, 2009·Pharmaceutical Research·Olga BorgesHans E Junginger
Jun 14, 2005·Current Opinion in Immunology·Andreas Wack, Rino Rappuoli
Jun 13, 2009·Journal of Biomaterials Science. Polymer Edition·Jeffrey R KovacsWilson S Meng
Dec 4, 2012·Journal of Nanobiotechnology·Mary C RegierAngela K Pannier
May 14, 2010·International Journal of Nanomedicine·Ana Maria Carmona-Ribeiro
Jan 1, 2009·Experimental & Molecular Medicine·Chae Young KimByung Gee Kim
Oct 15, 2013·Advances in Colloid and Interface Science·M Carmen MoránBjörn Lindman
Jun 6, 2012·Journal of Biomedicine & Biotechnology·C Vilos, L A Velasquez
Sep 30, 2014·Colloids and Surfaces. B, Biointerfaces·Amalia Mezei, Ramon Pons
Jul 20, 2005·Expert Review of Vaccines·Maxim PavlenkoPavel Pisa
Aug 3, 2007·Expert Review of Vaccines·Pål JohansenBruno Gander
Oct 27, 2007·Expert Opinion on Biological Therapy·Alain LuxembourgDrew Hannaman
Jul 30, 2005·Expert Opinion on Biological Therapy·Wilson S Meng, Lisa H Butterfield
Nov 22, 2005·Expert Opinion on Drug Delivery·H Oya AlparVincent W Bramwell
Feb 4, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·R Noelle PalumboChun Wang
Oct 31, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Rupei TangChun Wang
Jan 29, 2009·Advanced Drug Delivery Reviews·Hermann Wagner
Oct 5, 2007·Comparative Immunology, Microbiology and Infectious Diseases·Behazine Combadière, Brice Mahé
Sep 25, 2007·International Journal of Medical Microbiology : IJMM·Antje HeitFrank Schmitz
Apr 22, 2008·The Journal of Gene Medicine·Jukka HartikkaAlain Rolland
Aug 23, 2011·Microbial Biotechnology·Steffi Hansen, Claus-Michael Lehr
Jun 24, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sudhir Pai KasturiKrishnendu Roy
Mar 15, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jae-Hyung Jang, Lonnie D Shea
Apr 1, 2005·Drug Discovery Today. Technologies·Lea Ann Dailey, Thomas Kissel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.